Home Synta Pharmaceuticals Closes Public Offering of Common Stock
 

Keywords :   


Synta Pharmaceuticals Closes Public Offering of Common Stock

2013-11-19 12:52:57| Biotech - Topix.net

Gross proceeds to Synta are approximately $60.4 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by Synta.

Tags: public stock common offering

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
22.09Eastern North Pacific Tropical Weather Outlook
22.09Atlantic Tropical Weather Outlook
21.09Atlantic Tropical Weather Outlook
21.09Eastern North Pacific Tropical Weather Outlook
21.09Strategies to minimize fallback pigs in the nursery
21.09This Week in Agribusiness, Sept. 21, 2024
21.09This Week in Agribusiness, Sept. 21, 2024
21.09RABapp provides rapid response insight in animal health emergencies
More »